Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.14
+0.19 (2.73%)
At close: Jun 2, 2025, 4:00 PM
7.19
+0.05 (0.70%)
After-hours: Jun 2, 2025, 7:50 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $156.04 million as of June 2, 2025. Its market cap has increased by 410.33% in one year.
Market Cap
156.04M
Enterprise Value
168.41M
1-Year Change
410.33%
Ranking
Category
Stock Price
$7.14
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $156.04M, an increase of 147.27%. That is a compound annual growth rate of 17.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |